{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:35:25Z","timestamp":1760985325283,"version":"3.30.1"},"reference-count":30,"publisher":"Medknow","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pathol Microbiol"],"published-print":{"date-parts":[[2015]]},"DOI":"10.4103\/0377-4929.162831","type":"journal-article","created":{"date-parts":[[2015,8,14]],"date-time":"2015-08-14T09:35:20Z","timestamp":1439544920000},"page":"279","source":"Crossref","is-referenced-by-count":10,"title":["BRAF, KIT, NRAS, GNAQ and GNA11 mutation analysis in cutaneous melanomas in Turkish population"],"prefix":"10.4103","volume":"58","author":[{"given":"Ismail","family":"Yilmaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Gamsizkan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zafer","family":"Kucukodaci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilaver","family":"Demirel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aptullah","family":"Haholu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gizem","family":"Narli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ufuk","family":"Berber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2581","reference":[{"key":"key-10.4103\/0377-4929.162831-1","first-page":"283","volume-title":"Cancer statistics for Hispanics\/Latinos, 2012","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"key-10.4103\/0377-4929.162831-2","first-page":"2135","volume-title":"Distinct sets of genetic alterations in melanoma","author":"Curtin","year":"2005","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0377-4929.162831-3","first-page":"4340","volume-title":"Somatic activation of KIT in distinct subtypes of melanoma","author":"Curtin","year":"2006","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0377-4929.162831-4","first-page":"1446","volume-title":"Correlation between KIT expression and KIT mutation in melanoma: A study of 173 cases with emphasis on the acral-lentiginous\/mucosal type","author":"Torres-Cabala","year":"2009","journal-title":"Mod Pathol"},{"key":"key-10.4103\/0377-4929.162831-5","first-page":"949","volume-title":"Mutations of the BRAF gene in human cancer","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"key-10.4103\/0377-4929.162831-6","first-page":"362","volume-title":"Detection of B-RAF and N-RAS mutations in human melanoma","author":"Goydos","year":"2005","journal-title":"J Am Coll Surg"},{"key":"key-10.4103\/0377-4929.162831-7","first-page":"2191","volume-title":"Mutations in GNA11 in uveal melanoma","author":"Van","year":"2010","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0377-4929.162831-8","first-page":"599","volume-title":"Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi","author":"Van","year":"2009","journal-title":"Nature"},{"key":"key-10.4103\/0377-4929.162831-9","doi-asserted-by":"crossref","unstructured":"K\u00fcsters-Vandevelde HV, van Engen-van Grunsven IA, Coupland SE, Lake SL, Rijntjes J, Pfundt R, et al. Mutations in G protein encoding genes and chromosomal alterations in primary leptomeningeal melanocytic neoplasms [published online Oct 15 2014]. Pathol Oncol Res 2014. doi: 10.1007\/s12253-014-9841-3.","DOI":"10.1007\/s12253-014-9841-3"},{"key":"key-10.4103\/0377-4929.162831-10","first-page":"417","volume-title":"GNA11 and N-RAS mutations: Alternatives for MAPK pathway activating GNAQ mutations in primary melanocytic tumours of the central nervous system","author":"Gessi","year":"2013","journal-title":"Neuropathol Appl Neurobiol"},{"key":"key-10.4103\/0377-4929.162831-11","first-page":"763","volume-title":"Genetic and morphologic features for melanoma classification","author":"Broekaert","year":"2010","journal-title":"Pigment Cell Melanoma Res"},{"key":"key-10.4103\/0377-4929.162831-12","first-page":"471","volume-title":"NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: A study based on mutation screening by pyrosequencing","author":"Edlundh-Rose","year":"2006","journal-title":"Melanoma Res"},{"key":"key-10.4103\/0377-4929.162831-13","doi-asserted-by":"crossref","unstructured":"Amanuel B, Grieu F, Kular J, Millward M, Iacopetta B. Incidence of BRAF p.Val600Glu and p.Val600Lys mutations in a consecutive series of 183 metastatic melanoma patients from a high incidence region. Pathology 2012;44:357-9.","DOI":"10.1097\/PAT.0b013e3283532565"},{"key":"key-10.4103\/0377-4929.162831-14","first-page":"9","volume-title":"BRAF V600 mutations and pathological features in Japanese melanoma patients","author":"Yamazaki","year":"2015","journal-title":"Melanoma Res"},{"key":"key-10.4103\/0377-4929.162831-15","first-page":"177","volume-title":"BRAF point mutations in primary melanoma show different prevalences by subtype","author":"Sasaki","year":"2004","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0377-4929.162831-16","first-page":"94","volume-title":"Prevalence of BRAF V600E mutation in Chinese melanoma patients: large scale analysis of BRAF and NRAS mutations in a 432-case cohort","author":"Si","year":"2012","journal-title":"Eur J Cancer"},{"key":"key-10.4103\/0377-4929.162831-17","first-page":"1129","volume-title":"BRAF exon 15 T1799A mutation is common in melanocytic nevi, but less prevalent in cutaneous malignant melanoma, in Chinese Han","author":"Qi","year":"2011","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0377-4929.162831-18","first-page":"579","volume-title":"BRAF mutations and KIT aberrations and their clinicopathological correlation in 202 Korean melanomas","author":"Jin","year":"2013","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0377-4929.162831-19","first-page":"1878","volume-title":"Determinants of BRAF mutations in primary melanomas","author":"Maldonado","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"key-10.4103\/0377-4929.162831-20","first-page":"705","volume-title":"High BRAF mutation frequency does not characterize all melanocytic tumor types","author":"Saldanha","year":"2004","journal-title":"Int J Cancer"},{"key":"key-10.4103\/0377-4929.162831-21","first-page":"776","volume-title":"Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: A meta-analysis","author":"Lee","year":"2011","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0377-4929.162831-22","first-page":"1239","volume-title":"Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma","author":"Long","year":"2011","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0377-4929.162831-23","first-page":"3242","volume-title":"Distinguishing clinicopathologic features of patients with V600E and V600K BRAF-mutant metastatic melanoma","author":"Menzies","year":"2012","journal-title":"Clin Cancer Res"},{"key":"key-10.4103\/0377-4929.162831-24","first-page":"4014","volume-title":"NRAS mutation status is an independent prognostic factor in metastatic melanoma","author":"Jakob","year":"2012","journal-title":"Cancer"},{"key":"key-10.4103\/0377-4929.162831-25","first-page":"345","volume-title":"BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor site","author":"Bauer","year":"2011","journal-title":"Pigment Cell Melanoma Res"},{"key":"key-10.4103\/0377-4929.162831-26","first-page":"132","volume-title":"Targeting NRAS in melanoma","author":"Kelleher","year":"2012","journal-title":"Cancer J"},{"key":"key-10.4103\/0377-4929.162831-27","first-page":"229","volume-title":"Clinical correlates of NRAS and BRAF mutations in primary human melanoma","author":"Ellerhorst","year":"2011","journal-title":"Clin Cancer Res"},{"key":"key-10.4103\/0377-4929.162831-28","first-page":"640","volume-title":"BRAF and NRAS mutations are uncommon in melanomas arising in diverse internal organs","author":"Wong","year":"2005","journal-title":"J Clin Pathol"},{"key":"key-10.4103\/0377-4929.162831-29","first-page":"4345","volume-title":"Combination small molecule MEK and PI3K inhibition enhances uveal melanoma cell death in a mutant GNAQ- and GNA11-dependent manner","author":"Khalili","year":"2012","journal-title":"Clin Cancer Res"},{"key":"key-10.4103\/0377-4929.162831-30","first-page":"1905","volume-title":"Protein kinase C inhibitor AEB071 targets ocular melanoma harboring GNAQ mutations via effects on the PKC\/Erk1\/2 and PKC\/NF-\u03baB pathways","author":"Wu","year":"2012","journal-title":"Mol Cancer Ther"}],"container-title":["Indian Journal of Pathology and Microbiology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T17:39:41Z","timestamp":1498239581000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ijpmonline.org\/text.asp?2015\/58\/3\/279\/162831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015]]}},"alternative-id":["162831"],"URL":"https:\/\/doi.org\/10.4103\/0377-4929.162831","relation":{},"ISSN":["0377-4929"],"issn-type":[{"type":"print","value":"0377-4929"}],"subject":[],"published":{"date-parts":[[2015]]}}}